Prescription Drugs: Cost Effectiveness
Lords · Question HL15508 · Tabled 12 Mar 2026 · Department of Health and Social Care · Official record
Answered 23 Mar 2026
Question
Asked by Baroness Shawcross-Wolfson
To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 11 March (HL15135), in what circumstances a direction under the statutory instrument coming into force on 24 March would not be made.
Answer
Answered by Baroness Merron, 23 Mar 2026
It is important that there is stability in the medicines regulatory and access landscape, and there should be a high bar for making changes to the cost-effectiveness threshold. It is the Government’s intention, therefore, that the power to set the cost-ef...